1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H2, 2015

Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H2, 2015" provides an overview of Leishmaniasis (Kala-Azar) clinical trials scenario. This report provides top line data relating to the clinical trials on Leishmaniasis (Kala-Azar). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Leishmaniasis (Kala-Azar) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Leishmaniasis (Kala-Azar) to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Leishmaniasis (Kala-Azar) to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Leishmaniasis (Kala-Azar) 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
International Centre for Diarrhoeal Disease Research, Bangladesh 32
Clinical Trial Overview of International Centre for Diarrhoeal Disease Research, Bangladesh 32
Knight Therapeutics Inc. 33
Clinical Trial Overview of Knight Therapeutics Inc. 33
Medecins Sans Frontieres 34
Clinical Trial Overview of Medecins Sans Frontieres 34
Aeterna Zentaris Inc. 35
Clinical Trial Overview of Aeterna Zentaris Inc. 35
Zydus Cadila Healthcare Limited 36
Clinical Trial Overview of Zydus Cadila Healthcare Limited 36
Lifecare Innovations Private Limited 37
Clinical Trial Overview of Lifecare Innovations Private Limited 37
GVK Biosciences Private Limited 38
Clinical Trial Overview of GVK Biosciences Private Limited 38
Fast-Track Drugs and Biologics, LLC 39
Clinical Trial Overview of Fast-Track Drugs and Biologics, LLC 39
Cellestis Limited 40
Clinical Trial Overview of Cellestis Limited 40
Bharat Serums And Vaccines Limited 41
Clinical Trial Overview of Bharat Serums And Vaccines Limited 41
Clinical Trial Overview of Top Institutes / Government 42
Mashhad University of Medical Sciences 42
Clinical Trial Overview of Mashhad University of Medical Sciences 42
Banaras Hindu University 44
Clinical Trial Overview of Banaras Hindu University 44
Drugs for Neglected Diseases initiative 45
Clinical Trial Overview of Drugs for Neglected Diseases initiative 45
Tehran University of Medical Sciences 47
Clinical Trial Overview of Tehran University of Medical Sciences 47
Infectious Disease Research Institute 48
Clinical Trial Overview of Infectious Disease Research Institute 48
U.S. Army Medical Research and Materiel Command 49
Clinical Trial Overview of U.S. Army Medical Research and Materiel Command 49
AB foundation 50
Clinical Trial Overview of AB foundation 50
Hospital Universitrio Professor Edgard Santos 51
Clinical Trial Overview of Hospital Universitrio Professor Edgard Santos 51
University of Brasilia 52
Clinical Trial Overview of University of Brasilia 52
Centro de Investigaciones Bioclinicas de la Fundacion Fader 53
Clinical Trial Overview of Centro de Investigaciones Bioclinicas de la Fundacion Fader 53
Five Key Clinical Profiles 54
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 82

List of Tables
Leishmaniasis (Kala-Azar) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Leishmaniasis (Kala-Azar) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Leishmaniasis (Kala-Azar) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Leishmaniasis (Kala-Azar) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Leishmaniasis (Kala-Azar) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Leishmaniasis (Kala-Azar) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Leishmaniasis (Kala-Azar) to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Leishmaniasis (Kala-Azar) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Leishmaniasis (Kala-Azar) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Leishmaniasis (Kala-Azar) Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Leishmaniasis (Kala-Azar) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Leishmaniasis (Kala-Azar) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Leishmaniasis (Kala-Azar) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Leishmaniasis (Kala-Azar) Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Leishmaniasis (Kala-Azar) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by International Centre for Diarrhoeal Disease Research, Bangladesh, 2015* 32
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Knight Therapeutics Inc., 2015* 33
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medecins Sans Frontieres, 2015* 34
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aeterna Zentaris Inc., 2015* 35
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Zydus Cadila Healthcare Limited, 2015* 36
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Lifecare Innovations Private Limited, 2015* 37
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by GVK Biosciences Private Limited, 2015* 38
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fast-Track Drugs and Biologics, LLC, 2015* 39
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cellestis Limited, 2015* 40
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bharat Serums And Vaccines Limited, 2015* 41
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2015* 42
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Banaras Hindu University, 2015* 44
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Drugs for Neglected Diseases initiative, 2015* 45
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 47
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Infectious Disease Research Institute, 2015* 48
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Medical Research and Materiel Command, 2015* 49
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by AB foundation, 2015* 50
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitrio Professor Edgard Santos, 2015* 51
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Brasilia, 2015* 52
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centro de Investigaciones Bioclinicas de la Fundacion Fader, 2015* 53

List of Figures
Leishmaniasis (Kala-Azar) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Leishmaniasis (Kala-Azar) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Leishmaniasis (Kala-Azar) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Leishmaniasis (Kala-Azar) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Leishmaniasis (Kala-Azar) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Leishmaniasis (Kala-Azar) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Leishmaniasis (Kala-Azar) to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Leishmaniasis (Kala-Azar) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Leishmaniasis (Kala-Azar) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Leishmaniasis (Kala-Azar) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Leishmaniasis (Kala-Azar) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Leishmaniasis (Kala-Azar) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Leishmaniasis (Kala-Azar) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 81

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.